Statin use and risk of diabetes mellitus

At present time four groups of medications are used to correct dyslipidemia: bile acid sequestrants, niacin, fibric acid derivatives andstatins. During last years statins' potential to increase risk of type 2 diabetes mellitus (T2DM) is actively discussed, though no commonopinion about the poss...

Full description

Bibliographic Details
Main Authors: Oksana Mikhailovna Drapkina, Marina Viktorovna Kostyukevich
Format: Article
Language:English
Published: Endocrinology Research Centre 2012-06-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/5523
_version_ 1797255299830120448
author Oksana Mikhailovna Drapkina
Marina Viktorovna Kostyukevich
author_facet Oksana Mikhailovna Drapkina
Marina Viktorovna Kostyukevich
author_sort Oksana Mikhailovna Drapkina
collection DOAJ
description At present time four groups of medications are used to correct dyslipidemia: bile acid sequestrants, niacin, fibric acid derivatives andstatins. During last years statins' potential to increase risk of type 2 diabetes mellitus (T2DM) is actively discussed, though no commonopinion about the possible mechanism of such effect has evolved as yet. Insulin desensitizing effect as a class feature of statins remainsa disputable question.Position of statins as a first-line therapy for severe hyperlipidemia seems undoubted; however they do not improve insulin sensitivity.Moreover, several studies reported increased risk of T2DM. It is feasible to consider combined treatment (including metformin) inpatients from risk groups for development of T2DM, receiving statins
first_indexed 2024-03-08T15:21:38Z
format Article
id doaj.art-b31942a2c8ca41908837b15aa3f8aa17
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:03:39Z
publishDate 2012-06-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-b31942a2c8ca41908837b15aa3f8aa172024-03-20T11:47:57ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-06-01152778210.14341/2072-0351-55235481Statin use and risk of diabetes mellitusOksana Mikhailovna Drapkina0Marina Viktorovna Kostyukevich1I.M. Sechenov First Moscow State Medical University, MoscowI.M. Sechenov First Moscow State Medical University, MoscowAt present time four groups of medications are used to correct dyslipidemia: bile acid sequestrants, niacin, fibric acid derivatives andstatins. During last years statins' potential to increase risk of type 2 diabetes mellitus (T2DM) is actively discussed, though no commonopinion about the possible mechanism of such effect has evolved as yet. Insulin desensitizing effect as a class feature of statins remainsa disputable question.Position of statins as a first-line therapy for severe hyperlipidemia seems undoubted; however they do not improve insulin sensitivity.Moreover, several studies reported increased risk of T2DM. It is feasible to consider combined treatment (including metformin) inpatients from risk groups for development of T2DM, receiving statinshttps://www.dia-endojournals.ru/jour/article/view/5523statinsinsulin resistancediabetes mellitusatherosclerosismetformin
spellingShingle Oksana Mikhailovna Drapkina
Marina Viktorovna Kostyukevich
Statin use and risk of diabetes mellitus
Сахарный диабет
statins
insulin resistance
diabetes mellitus
atherosclerosis
metformin
title Statin use and risk of diabetes mellitus
title_full Statin use and risk of diabetes mellitus
title_fullStr Statin use and risk of diabetes mellitus
title_full_unstemmed Statin use and risk of diabetes mellitus
title_short Statin use and risk of diabetes mellitus
title_sort statin use and risk of diabetes mellitus
topic statins
insulin resistance
diabetes mellitus
atherosclerosis
metformin
url https://www.dia-endojournals.ru/jour/article/view/5523
work_keys_str_mv AT oksanamikhailovnadrapkina statinuseandriskofdiabetesmellitus
AT marinaviktorovnakostyukevich statinuseandriskofdiabetesmellitus